The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Open accessAbstract
It has been reported that soluble interleukin (IL)-6 receptor (sIL-6R) is detected in the serum of healthy individuals and its level is increased in patients with multiple myeloma and human immunodeficiency virus infection. Although several reports have suggested that sIL-6R potentiates IL-6 action, its physiological role remains unclear. In this study, we examined the role of sIL-6R on osteoclast formation by IL-6, using a coculture of mouse osteoblasts and bone marrow cells. Neither recombinant mouse IL-6 (mIL-6) nor mouse sIL-6R (smIL-6R) induced osteoclast-like multinucleated cell (MNC) formation when they were added separately. In contrast, simultaneous treatment with mIL-6 and smIL-6R strikingly induced MNC formation. These MNCs satisfied major criteria of authentic osteoclasts, such as tartrate-resistant acid phosphatase (TRAP) activity, calcitonin receptors, and pit formation on dentine slices. The MNC formation induced by mIL-6 and smIL-6R was dose-dependently inhibited by adding monoclonal anti-mouse IL-6R antibody (MR16-1). It is likely that osteoblasts and osteoclast progenitors are capable of transducing a signal from a complex of IL-6 and sIL-6R through gp130, even though they may have no or a very small number of IL-6Rs. Factors such as IL-11, oncostatin M, and leukemia inhibitory factor, which are known to exert their functions through gp130 (the signal-transducing chain of IL-6R), also induced MNC formation in our coculture system. These results suggest that increased circulating or locally produced sIL-6R induces osteoclast formation in the presence of IL-6 mediated by a mechanism involving gp130. This may play an important physiological or pathological role in conditions associated with increased osteoclastic bone resorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
Self-citationIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Self-citationIL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Self-citationModulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Self-citationOSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 933
Self-citationExcessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Klein, B., Zhang, X., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., & Bataille, R. (1989) · Blood · doi:10.1182/blood.v73.2.517.517 · Cited by 763
TAKAHASHI, N., YAMANA, H., YOSHIKI, S., ROODMAN, G. D., MUNDY, G. R., JONES, S. J., BOYDE, A., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-122-4-1373 · Cited by 730
Self-citationGirasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., & Manolagas, S. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115668 · Cited by 679
Interleukin-6 and its receptor: a paradigm for cytokines
Kishimoto, T., Akira, S., & Taga, T. (1992) · Science · doi:10.1126/science.1411569 · Cited by 665
Self-citationSoluble cytokine receptors are present in normal human urine.
Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1409 · Cited by 434
Löwik, C. W. G. M., van der Pluijm, G., Bloys, H., Hoekman, K., Bijvoet, O. L. M., Aarden, L. A., & Papapoulos, S. E. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90851-6 · Cited by 373
Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
Mackiewicz, A., Schooltink, H., Heinrich, P. C., & Rose-John, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2021 · Cited by 370
Human soluble IL-6 receptor: its detection and enhanced release by HIV infection
Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Osugi, Y., Tokunaga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2175 · Cited by 331
Perspectives: Interleukin-6: An osteotropic factor?
Roodman, G. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070502 · Cited by 272
Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
Yin, T., Taga, T., Tsang, M. L., Yasukawa, K., Kishimoto, T., & Yang, Y. C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2555 · Cited by 262
Self-citationRole of prostaglandins in interleukin-1-induced bone resorption in mice in vitro
Akatsu, T., Takahashi, N., Udagawa, N., Imamura, K., Yamaguchi, A., Sato, K., Nagata, N., & Dr. Suda, T. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060212 · Cited by 235
Self-citationBlack, K., Garrett, I. R., & Mundy, G. R. (1991) · Endocrinology · doi:10.1210/endo-128-5-2657 · Cited by 199
Gaillard, J., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T., & Klein, B. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230408 · Cited by 196
Self-citationAkatsu, T., Takahashi, N., Debari, K., Morita, I., Murota, S., Nagata, N., Takatani, O., & Suda, T. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040106 · Cited by 187
Self-citationThe Modulation of the Expression of IL-6 and Its Receptor in Human Osteoblastsin Vitro*
Littlewood, A. J., RUSSELL, J., Harvey, G., Hughes, D. E., Russell, R. G. G., & Gowen, M. (1991) · Endocrinology · doi:10.1210/endo-129-3-1513 · Cited by 164
Preparation and characterization of a mouse osteoclast-like multinucleated cell population
Akatsu, T., Tamura, T., Takahashi, N., Udagawa, N., Tanaka, S., Sasaki, T., Yamaguchi, A., Nagata, N., & Suda, T. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071109 · Cited by 155
Self-citationPurification and Characterization of Soluble Human IL-6 Receptor Expressed in CHO Cells
Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishihara, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawata, H., Hirano, T., et al. (1990) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123261 · Cited by 145
Self-citationSuzuki, H., Yasukawa, K., Saito, T., Narazaki, M., Hasegawa, A., Taga, T., & Kishimoto, T. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230515 · Cited by 103
Self-citationInterleukin-6 does not stimulate bone resorption in neonatal mouse calvariae
Al‐Humidan, A., Ralston, S. H., Hughes, D. E., Chapman, K., Aarden, L. A., Russell, R. G. G., & Gowen, M. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060103 · Cited by 98
New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro
Tamura, T., Takahashi, N., Akatsu, T., Sasaki, T., Udagawa, N., Tanaka, S., & Suda, T. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080808 · Cited by 96
Self-citationAkatsu, T., Takahashi, N., Udagawa, N., Sato, K., Nagata, N., Moseley, J. M., Martin, T. J., & Suda, T. (1989) · Endocrinology · doi:10.1210/endo-125-1-20 · Cited by 95
Self-citationPreparation of soluble murine IL-6 receptor and anti-murine IL-6 receptor antibodies
Saito, T., Yasukawa, K., Suzuki, H., Futatsugi, K., Fukunaga, T., Yokomizo, C., Koishihara, Y., Fukui, H., Ohsugi, Y., & Yawata, H. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.168 · Cited by 56
Self-citationIL 3 and IL 6 do not induce bone resorption in vitro
Barton, B. E., & Mayer, R. (1990) · Cytokine · doi:10.1016/1043-4666(90)90019-p · Cited by 30
Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation.
Taga, T., & Kishimoto, T. (1992) · PubMed · Cited by 28
Self-citation
Cited by
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Self-citationManolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Self-citationKishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,328
Self-citation
Metadata
- Authors
- Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-12-15
- Volume
- 90
- Issue
- 24
- Pages
- 11924-11928
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2066385294
- Cited by
- 825
- References
- 31
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.